Why the study?
Despite the recognized burden of hospital readmissions, few studies have focused on readmissions among patients with diabetes, leading the authors to evaluate whether HbA1C values predict readmission risk.
Are HbA1C values associated with 30-day hospital readmission rates in patients with diabetes?
Are HbA1C values associated with 30-day hospital readmission rates in patients with diabetes?
While baseline HbA1C does not predict overall 30-day readmissions in diabetic patients, higher levels are associated with multiple readmissions within a 30-day period.
HbA1c should not yet guide 30-day readmission risk stratification in diabetes; leaves open association with recurrent events for prospective study.
The purpose of this study is to evaluate the role of HbA1C and its impact on hospital readmission. Despite widespread recognition of the burden of hospital readmissions, there are only a few studies focused on readmissions among patients with diabetes. We hypothesize that HbA1C values are associated with hospital readmission rates and would be an important indicator of risk of hospital readmission. The primary outcome in our study was that while HbA1C did not play a role in predicting 30-day readmissions, patients with multiple readmissions within 30 days had a significantly higher HbA1C level as compared to those with one readmission. Secondary findings in our study included: 1) patients with a primary diagnosis of diabetes had a significantly higher HbA1C than those with a secondary diagnosis, 2) patients admitted with a primary diagnosis of diabetes had a higher incidence of HbA1C testing than those admitted with a secondary diagnosis of diabetes.
No takes yet. Share an insight, caveat, or question.
Bakeri et al. (2018) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: